Technical Analysis for MNTM - Mount Tam Biotechnologies Inc.

Grade Last Price % Change Price Change
grade F 0.0091 1.11% 0.0001
MNTM closed up 1.11 percent on Friday, October 11, 2019, on 4 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MNTM trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 1.11%
180 Bearish Setup Bearish Swing Setup 1.11%
Narrow Range Bar Range Contraction 1.11%
NR7 Range Contraction 1.11%

Older signals for MNTM ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Mount Tam Biotechnologies, Inc., formerly TabacaleraYsidron, Inc., is a specialty biopharmaceutical company established to develop and bring to market a portfolio of pharmaceutical products targeting the treatment of autoimmune diseases. The Company is focused on the development of product candidate in the field of systemic lupus erythematosus (SLE), an orphan autoimmune disease. The Company's product candidate, TAM-01, is a rapamycin analog, which exerts its action through direct binding and inhibition of the mammalian Target of Rapamycin (mTOR). mTOR is a key regulatory pathway, which is altered in individuals suffering from autoimmune disorders, including lupus. The Company's product candidate, TAM-01, is a small-molecule inhibitor of mTOR. TAM-01 has completed preliminary toxicology, safety, pharmacokinetics (PK), absorption, distribution, metabolism and excretion (ADME), and preliminary scale up manufacturing studies.
Medicine Medical Specialties Branches Of Biology Biopharmaceutical Pharmaceutical Products Autoimmune Diseases Autoimmunity Pharmacokinetics Lupus Treatment Of Autoimmune Diseases Autoimmune Disorders Systemic Lupus Erythematosus
Is MNTM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.175
52 Week Low 0.0051
Average Volume 155,371
200-Day Moving Average 0.0325
50-Day Moving Average 0.025
20-Day Moving Average 0.0208
10-Day Moving Average 0.0169
Average True Range 0.009
ADX 18.66
+DI 34.4524
-DI 24.3805
Chandelier Exit (Long, 3 ATRs ) 0.0529
Chandelier Exit (Short, 3 ATRs ) 0.035200000000000001
Upper Bollinger Band 0.0372
Lower Bollinger Band 0.0044
Percent B (%b) 0.14
BandWidth 157.692308
MACD Line -0.0038
MACD Signal Line -0.0024
MACD Histogram -0.0014
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0091
Resistance 3 (R3) 0.0091 0.0091 0.0091
Resistance 2 (R2) 0.0091 0.0091 0.0091 0.0091
Resistance 1 (R1) 0.0091 0.0091 0.0091 0.0091 0.0091
Pivot Point 0.0091 0.0091 0.0091 0.0091 0.0091
Support 1 (S1) 0.0091 0.0091 0.0091 0.0091 0.0091
Support 2 (S2) 0.0091 0.0091 0.0091 0.0091
Support 3 (S3) 0.0091 0.0091 0.0091
Support 4 (S4) 0.0091